In conclusion, the regulation of the MDM2 gene by MIR17HG, which leads to the downregulation of miRNA hsa‐mir‐425‐5p levels during RB development, can alleviate p53‐mediated inhibition of the cell cycle by blocking the p53 signaling pathway. Here, MDM2 is linked to retinoblastoma.